Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stemedica itMSC in Knee Osteoarthritis
NCT03602872Phase 1Withdrawn
- Sponsor
- Clinica Santa Clarita
- Start
- Aug 2019
- Primary completion
- Apr 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of mesenchymal stem cells in knee osteoarthritis (OA) (3 arms), sponsored by Clinica Santa Clarita. Primary endpoint: Safety evaluation of all AE/SAEs. Planned start Aug 2019; status: withdrawn.
02
Drugs
mesenchymal stem cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03602872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03602872.